Univ. of South Florida Bd. of Trustees v. United States, Appeal No. 2022-2248 (Fed. Cir. Feb. 9, 2024)
In this week’s Case of the Week, the Federal Circuit examined the scope of a provision of the Bayh-Dole Act of 1980 (35...more
2/14/2024
/ Appeals ,
Bayh-Dole Act ,
Claim Construction ,
Federal Funding ,
Final Written Decisions ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Post-Grant Review ,
Prior Art
SNIPR Technologies Limited v. Rockefeller University, Appeal No. 2022-1260 (Fed. Cir. July 14, 2023)
Our case of the week addresses a wrinkle in the law concerning disputes between parties that filed patent applications...more
7/18/2023
/ America Invents Act ,
Appeals ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inventions ,
Motion to Dismiss ,
Nonobvious ,
Patent Applications ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Remand ,
Vacated
Yita LLC v. MacNeil IP LLC, Appeal Nos. 2022-1373, -1374 (Fed. Cir. June 6, 2023)
In appeals from two inter partes reviews before the Patent Trial and Appeal Board (the Board) on related patents, the Federal Circuit...more
6/12/2023
/ Appeals ,
Claim Construction ,
Design Patent ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Inventors ,
Nonobvious ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents
Belcher Pharmaceuticals, LLC v. Hospira, Inc., Appeal No. 2020-1799 (Fed. Cir. Sept. 1, 2021) -
In an appeal from the United States District Court for the District of Delaware, the Federal Circuit affirmed the district...more
9/8/2021
/ Appeals ,
Failure To Disclose ,
Food and Drug Administration (FDA) ,
Inequitable Conduct ,
Inventions ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Notice ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Trademarks ,
USPTO
Our Case of the Week this week is a re-write of our Case of the Week on October 5, 2020. The case involves a drug that could be used for multiple therapeutic purposes. A patent covered use of the product for a specific...more
8/10/2021
/ Appeals ,
Damages ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Improper Venue ,
Inventions ,
Labeling ,
Liability ,
Motion to Dismiss ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Subject Matter Jurisdiction